Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Clinical trial NCT02871323 · WITHDRAWN

Trial details

NCT number: NCT02871323
Sponsor: Northwestern University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Primary Myelofibrosis

Start date: 2016-11-01
Primary completion: 2016-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.